Edition:
International

Lewis Krauskopf

Stocks steady as markets calm after Evergrande-led slide

Sep 21 2021

NEW YORK/LONDONWorld stock markets stabilized on Tuesday and oil prices regained ground a day after heavy selling of risk assets, as investors assessed the level of contagion stemming from distress at developer China Evergrande and awaited central bank meetings. | Video

GLOBAL MARKETS-Stocks steady as markets calm after Evergrande-led slide

Sep 21 2021

* Key central bank meetings this week in U.S., Britain, Japan

GLOBAL MARKETS-Stocks claw back as markets calm after Evergrande-led slide

Sep 21 2021

* Key central bank meetings this week in U.S., Britain, Japan

GLOBAL MARKETS-World stock markets steady after Evergrande-led sell-off

Sep 21 2021

* Key central bank meetings this week in U.S., Britain, Japan

World shares sink as China Evergrande fears spark risk off

Sep 20 2021

World stocks sold off sharply on Monday while safe-haven assets gained as troubles at property group China Evergrande fed concerns about spillover risks to the economy, sparking fresh investor worries ahead of a busy week of central bank meetings.

GLOBAL MARKETS-World shares sink as China Evergrande fears spark risk off

Sep 20 2021

* Fed, other central banks on tap later in the week (Updates with close of U.S. markets)

GLOBAL MARKETS-World shares tumble as China Evergrande contagion fears spread

Sep 20 2021

* MSCI global stock index set for biggest drop since Oct 2020

GLOBAL MARKETS-World shares tumble as China Evergrande contagion fears rise

Sep 20 2021

Sept 20 World stocks tumbled on Monday and the dollar firmed as troubles at property group China Evergrande sparked concerns about spillover risks to the economy, creating a fresh investor worry ahead of a busy week of central bank meetings.

Analysis-Torrid Moderna stock rally cools over booster shot doubts

Sep 17 2021

NEW YORK Debate over the need for COVID-19 booster shots is clouding the outlook for Moderna Inc's high-flying shares after the U.S. biotechnology company's stock price soared as much as 360% this year, making it the best performer in the S&P 500.

ANALYSIS-Torrid Moderna stock rally cools over booster shot doubts

Sep 17 2021

NEW YORK, Sept 17 Debate over the need for COVID-19 booster shots is clouding the outlook for Moderna Inc's high-flying shares after the U.S. biotechnology company's stock price soared as much as 360% this year, making it the best performer in the S&P 500.

World News